MADELINE LOVRENSKY: Open Payments
NPI 1801448956 · YUBA CITY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$364 in 15 payments from 5 companies in 2025. Trend: 2023 $110 · 2024 $164 · 2025 $364
Food & beverage: $364
| Company | Payments | Amount |
|---|---|---|
| Sage Therapeutics, LLC | 9 | $149 |
| AstraZeneca Pharmaceuticals LP | 1 | $123 |
| Supernus Pharmaceuticals, Inc. | 3 | $59 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Novo Nordisk Inc | 1 | $16 |
Products named: ZURZUVAE, AIRSUPRA, Qelbree, MYFEMBREE, Rybelsus.
Industry payments across CA — which companies pay providers there.
